Inflammation in atherosclerosis: from pathophysiology to practice

Area of Science:

• Cardiovascular Biology
• Immunology
• Pathophysiology

Background:

• Atherosclerosis was traditionally viewed as a cholesterol-driven process involving smooth muscle cells.
• Recent research implicates immune cells and inflammatory mediators in atherogenesis.
• Inflammation is now recognized as a central mechanism linking atherosclerosis risk factors to arterial changes.

Purpose of the Study:

• To review the evolving understanding of inflammation's role in atherosclerosis.
• To highlight the interplay between innate and adaptive immunity in atherogenesis.
• To discuss the translation of basic science advances into clinical practice for atherosclerosis management.

Main Methods:

• Review of current scientific literature on inflammation and atherosclerosis.
• Analysis of evidence implicating immune pathways in atherogenesis.
• Synthesis of findings on the balance of immune stimulatory and inhibitory pathways.

Main Results:

• Inflammation is a key regulatory process in atherosclerosis development and complications.
• Both innate and adaptive immunity play significant roles in atherogenesis.
• Understanding these inflammatory pathways provides new clinical perspectives.

Conclusions:

• The pathophysiology of atherosclerosis is fundamentally linked to inflammation.
• Advances in understanding immune mechanisms offer potential for improved patient management.
• Translational research promises to transform clinical practice in treating atherosclerosis.